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N-terminal sequenceVDACs (Voltage Dependent Anion selective Channels) are a family of pore-forming proteins discovered in the
mitochondrial outer membrane. In the animal kingdom, mammals show a conserved genetic organization of
the VDAC genes, corresponding to a group of three active genes. Three VDAC protein isoforms thus exist.
From a historically point of view most of the data collected about this protein refer to the VDAC1 isoform,
the ﬁrst to be identiﬁed and also the most abundant in the organisms. In this work we compare the informa-
tion available about the three VDAC isoforms, with a special emphasis upon the human proteins, here consid-
ered prototypical of the group, and we try to shed some light on speciﬁc functional roles of this apparently
redundant group of proteins. A new hypothesis about the VDAC(s) involvement in ROS control is proposed.
This article is part of a Special Issue entitled: VDAC structure, function, and regulation of mitochondrial
metabolism.
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VDACs (Voltage Dependent Anion selective Channels), also known as
mitochondrial porins, have been discovered in the outer mitochondrialucture, function, and regulation
Geological and Environmental
ia, Building 2, 3th ﬂoor, Campus
7384244; fax:+39 095580138.
l rights reserved.membrane about 40 years ago, when Schein et al, detected a pore-
forming activity in an extract of Paramecium tetraurelia mitochondria
[1]. In the next years a large wealth of data from practically all the
most studied living beings has come out about this surprising protein,
whose relevance in the cell has not yet been outlined enough. A uni-
fying view about VDAC has sprung out from these studies. VDAC is a
protein that bears extremely conserved structural and functional fea-
tures (despite major difference in the sequence) and this is a clue of
its important role [2,3].
A further intriguing observation is now coming in strict actuality.
In the cell a set of VDAC proteins has evolved, as has been discovered
1467A. Messina et al. / Biochimica et Biophysica Acta 1818 (2012) 1466–1476already since 1993 by the genetic screening of a cDNA library [4]
after the ﬁrst primary amino acid sequence was known by direct
sequencing of human VDAC1 [5]. These further molecules have
been simply numbered in the order of their discovery as VDAC2,
VDAC3, VDACn ...., leaving to the ﬁrstly studied isoform the acro-
nym VDAC1. The important point is that most information available
on VDAC came from the isoform VDAC1, the most abundant, or
from mixtures of more isoforms, as it has been proposed in [6,7],
that were not resolved at the time of their studies. This point thus
poses an urgent and demanding question to the audience of scien-
tists involved in VDAC and in those willing to know the real func-
tion of these protein(s): how many of the information present in
the literature are really due to VDAC1 and what is the inﬂuence of
the other isoforms in the functions generically attributed to VDAC?
In other words, why are there in the cell more VDAC isoforms? In
this work we try to shed some light about this underestimated but
important topic of the research about VDAC (see also [8,9]).
An additional caveat has to be added at this point: despite most of
the studied organisms show a variety of VDAC genes and isoforms,
and all of them have been named in their order of appearance in
the scientiﬁc arena, one has to be careful about their correspondence
since they evolved differently. For example the plant isoforms VDAC1,
2 and 3 do not correspond at all to the same names in mammals or
insects. This review is thus limited to the eutherians, i.e. the placen-
tal mammals, since all these animals have ﬁxed in their genomes the
same number of functional VDAC genes that share the same genetic
origin. Furthermore human VDACs are member of this group.
2. VDAC isoforms in mammals
The evolutionary history of VDAC isoforms has been extensively
analysed. The most recent work by Young et al.[10] used a combina-
tion of Neighbour-Joining and Bayesian methods upon the largest
set of sequences available at the moment. The rise of the three iso-
forms in the mammals was next to the separation between animals
and fungi VDACs, that derive from a common ancestor.
Inmammals (but also in most chordates) there are three clades cor-
responding to VDAC1, 2 and 3 isoforms. The assumption that VDAC3 is
the oldest protein is generally accepted. The divergence between
VDAC3 and VDAC1/2 has been estimated 365±60 MY ago, while the
divergence between VDAC1 and VDAC2 289±63 MY [10,11]. VDAC1
can be considered the most recent mitochondrial porin.
It has been proposed that the duplications that gave rise to the
multigene family of VDACs probably occurred independently in ani-
mals and plants after the divergence between the two kingdoms
[12,13] and this conclusion explains the unrelatedness between the
numbering of plant and animal isoforms.
The structure of VDAC eutherian genes is very similar. This concept
is outlined in Fig. 1 where the coding structure of the human VDAC
genes is reported. The genes are made of the same number of coding
exons, sharing exactly the same size, with the VDAC2 gene containing
an additional ﬁrst exon encoding for the short pre-sequence of 11
amino acids, a peculiar feature of this isoform. The intron size varies
from gene to gene but the striking point is the similarity among theVDAC1
VDAC2
VDAC3
Fig. 1. Structure of genes’ moieties coding for VDAC isoforms in humans. The exons coding
coding for untranslated transcripts are shown. The arrows show the ATG positions. The ba
length of the gene sequences encompassed between the Start and Stop codons are reporteexon organization that is conserved among the whole eutherian
group. VDAC paralogous genes evolved quite recently and conserved
similar structures for the coding region and even for intron/exon junc-
tions [14–16]. As it was acutely observed by Young [10], the exon-
intron boundary conservation means that there is intron phase correla-
tion: this phenomenon is viewed as evidence of non-random insertion
of introns [17]. Interestingly, these E–I boundaries, according to the
recently proposed 19 β-strands structure of the pore [18–20], local-
ize individual structural units corresponding to the N-terminal end
and to distinct blocks of β-strands (see Fig. 7 in [8]). The introns
usually do not interrupt secondary structure elements; even struc-
tural protein motifs, like the GLK motif and the "eukaryotic porin
signature motif" (Prosite PS00558) are not interrupted. This obser-
vation support the exon-shufﬂing theory about the origin of VDAC
genes from simpler units containing elementary building blocks
(this hypothesis has been recently investigated with the construc-
tion of artiﬁcial pores [21]).
Trascription of the VDAC isoform genes was studied with various
techniques. Northern blot and/or PCR analysis showed that the three
mammalian VDAC isoforms are expressed more or less ubiquitously
[4,14,22–24]. In liver the amount of VDAC transcripts is usually lower
than in the other tissues. VDAC2 and expecially VDAC3 are highly
expressed in testis [23,25], while mouse VDAC1 is poorly expressed in
this tissue [25]. In a recent study, Real Time PCR analysis of the
three isoforms in mRNA from HeLa cells showed that the VDAC1
mRNA is the most abundant and overcomes VDAC2 of one order of
magnitude and VDAC3 of two o. of m. [9]. The RT-PCR dosage of tran-
scripts after over-expression of each single isoforms showed that
VDAC2 and VDAC3 mRNA levels are inﬂuenced by the other iso-
forms, indicating the probable presence of coordination in the ex-
pression of VDAC gene isoforms [9].
The data reported above come from teams actively involved in
VDAC. If one, instead, browses the results of high throughput genome
expression analysis, he will ﬁnd that the picture is much more
complicated and maybe confusing. For example, in the NCBI, at
the address http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/index.
html, the search for VDAC genes in human produces a very large amount
of data. The three genes are expressed at high level, in particular VDAC1,
5.3 times the average gene in the present release of the Database. Some
hundreds of GenBank accessions for each gene derived from sequenced
cDNA were obtained by several tissues. Not unexpectedly, such kind
of results outlines the possible presence of more exons and introns
than those shown above for the canonical VDAC sequences. The poten-
tial proteins produced by these cDNA is rather high and it is useless to
enumerate them until there is no indication of their presence in the
cell. Two conclusions can be drawn from these information: the
VDAC3 is the simplest and smallest gene among the three; alternative
splicing is a reportedly common trait also for VDAC genes [6,8,26] but
its functional meaning is not known [27].
2.1. VDAC isoforms distribution in mitochondria
What is the distribution of VDAC isoforms in the mitochondrial
network? In a recent paper, the adoption of STED (two colorsChr
V
X
VIII
Length
20,2 kbp
19,8 kbp
11,3 kbp
for the proteins are shown. Their size is in scale but neither the introns nor the exons
ll and stick show the Stop codon position. The chromosome (Chr) localization and the
d.
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resolution of ~40 nm, was useful to determine the detailed pattern
of sub-mitochondrial distribution of VDAC isoforms [28]. While
VDAC1 and VDAC2 have a common pattern of distribution, with clus-
ters of higher abundance gapped by area relatively less populated,
VDAC3 is more homogeneously distributed along the network. This
is an indication of different utilization of the three isoforms.3. VDAC isoforms: puriﬁcation and structure
3.1. VDAC protein puriﬁcation
Puriﬁcation of VDAC from mammals and other species has been
accomplished since long time and established protocols exist [29,8].
In this context, we will emphasize deductions into the cellular prop-
erties of this protein, obtained from the puriﬁcation procedure. Fur-
thermore we will update the state of art about puriﬁcation of the
mammalian VDAC isoforms from tissues.
The basic, but fundamental, steps for the VDAC puriﬁcation are
three: the detergent used, the adoption of hydroxyapatite (HTP) to-
gether with celite as the chromatographic material and the concentra-
tion of membrane phospholipids in the extract, that is empirically
dependent on the ratio between the detergent and the mitochondrial
membrane material during the solubilization process: i.e. the most
diluted is the membrane protein to be solubilized, the lowest phos-
pholipid concentration is obtained in the detergent extract.
The combination of these three elements gives the extraordinary
result of the puriﬁcation of VDAC in a single chromatographic step,
with the VDAC being eluted in the not-retained or pass-through
material [29]. This essential strategy was applied to any organism
or tissues (Fig. 2) and it is also the basis in more complex strategies,
in case of speciﬁc contaminants [8].
What does this surprising observation tell us about VDAC in the
natural bilayer membrane?
In the mixture of the several integral membrane protein and
phospholipids obtained during the solubilization, the hydrophobic
proteins are engulfed in micelles and only protruding, hydrophilic
moieties can interact with the stationary phase of chromatographic
materials. If the stationary phase is only HTP, a calcium phosphate
crystal, the addition to the eluent buffer of salts or, better, of phos-
phate, improves the elution of adsorbed proteins. On the other side,
the inclusion of celite in the chromatographic material enhances
the adsorption of proteins because the contribution of van der Waals
forces is raised. This chromatography is thus able to adsorb all
the mitochondrial membrane proteins solubilized by, for example,
Triton X-100, but VDAC. This indicates that in this situation VDAC37K
25K
2D-SDS-PAGE
Western blotCoomassie Western blot
Fig. 2. Puriﬁcation and analysis of VDAC2 from spermatozoa. From left to right the
panels refer to the HTP/celite eluate of Triton X-100 solubilized bovine spermatozoa
analysed by one-dimension SDS-PAGE (staining with Coomassie blue or Western blot
with anti-VDAC2 speciﬁc Abs; TE: Triton Extract, HTP: chromatographic pass-through)
or by two-dimension electrophoresis. Viviana Menzel and Elvira Hinsch (Giessen,
Germany) are acknowledged for the image of 2-D gel.in the micelle does not expose any proteic part able to interact
with the stationary phase and thus is the most membrane-embedded
protein among themitochondrial proteins. This conclusion is supported
by the results obtainedwith different detergents. Additional moieties of
membrane proteins in micelles are exposed when the hydrophilic arm
of the detergent used for the solubilization is shortened. For example,
when, in the same conditions, LDAO (lauryl-(dimethyl)amine-oxide)
is used instead of Triton X-100, no protein at all is found in the HTP/
celite pass-through and also VDAC is retained [30]. High concentration
of phospholipids in the solubilized material shield the protruding
parts of other membrane proteins and cause their elution in the HTP
or HTP/celite pass-through. This property has been experimentally
demonstrated with the puriﬁcation of various metabolite carriers,
whose elution is favoured by the addition in the elution buffer of exter-
nally added phospholipids, including cardiolipin [31,32].
Two questions arise at this point: is this puriﬁcation procedure
able also to rid the other isoforms of and, if so, how reliable are the
data reported in the literature that usually refers to VDAC1?
The latter point is concerned with the electrophoretic mobility of
VDAC1, lower than expected [6,32]. VDAC2, despite the higher mo-
lecular weight, is mobile as VDAC1. VDAC3 is the faster isoform
[6,7]. The presence of more isoforms in HTP/celite eluates has been
also shown by Menzel et al.[7]. However, they used as starting mate-
rial not puriﬁed mitochondria but whole bovine spermatozoa. In
their paper, the eluate was further separated by 2D-electrophoresis
(Fig. 2), showing a plurality of spots that were identiﬁed as the var-
ious isoforms by Mass Spectrometry [7]. HTP/celite chromatography
can be succesfully applied to all the isoforms, indicating that they
have similar chemico-physical features in the context of a parti-
tioned hydrophobic/hydrophilic environment.
The information reported by several laboratories, in the last two
decades, is attributed to VDAC1. Have been these observations biased
by the contamination with other isoforms? To rule out any contami-
nation of puriﬁed proteins by others, with similar features, one
should adopt either a speciﬁc labelling, to track the protein of interest,
or a more powerfull analytical method, like 2-D electrophoresis. In
one of the oldest work about VDAC1, this protein was identiﬁed and
puriﬁed as the DCCD-binding protein [33]. DCCD (dicyclohexylcarbo-
diimide) binds acidic groups in an hydrophobic environment. The
DCCD binding residue was found to be the glutamic acid in position
72 in mammalian VDAC1 by direct sequencing of the corresponding
peptide [34]. This glutamic acid is present only in the sequences of
VDAC1 and 2 (Fig. 3). The Edman degradation of the corresponding
peptide should have had revealed the presence of VDAC2 contamina-
tion but it did not, indicating that the protein puriﬁed in that experi-
ment was only VDAC1. Also the few reports showing 2-D analysis of
puriﬁed VDAC1 did not show the presence of alternative spots later
found to be VDAC2 or VDAC3 [35,36].
These data indicate that the protein puriﬁed and analyzed in the
literature was essentially the same orthologus isoform, that has
been later called VDAC1. It is in fact correct to correlate most func-
tional information available to this protein isoform.3.2. VDAC protein structure
Fig. 3 shows the sequence alignment of the three human VDAC iso-
forms togetherwith yeast porin1. Table 1 shows the amino acid compo-
sition of the three isoforms. Fig. 4 is a comparative secondary structure
prediction obtained by the PSIPRED server. The observation of frequent,
short β-strands with alternating hydrophilic/hydrophobic residues in
the sequence has inspired several predictive models of the VDAC struc-
ture (for a review see Ref. [37]).
VDAC1 has been recently crystallized and the proposed structure
[18–20] is formed by a large transmembrane channel, made of 19
amphipathic β-strands, with the addition of an N-terminal sequence
Fig. 3. Alignments of human VDAC isoforms and porin1 from yeast. In yellow the position of cysteines is outlined.
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protein [38].
In this structure a wide, open barrel is formed through the regular
organization of up-and-down antiparallel β-strands. This pattern is
interrupted by the parallel disposition of the strands 1 and 19,
which are forced to run parallel. It is not known whether this excep-
tion to the rule of even numbers strands in β-barrels, well established
in bacteria [39], could have any inﬂuence on the stability of this struc-
ture. A whole criticism against this structure has been raised [40]. It is
based on several, possible problems that could have led to the pro-
posed crystallized structure. Among them, the consideration that
the artiﬁcial folding procedure used to prepare enough material for
the crystallization efforts might produce two (or more) populations
of stable VDAC structures and the proposed crystallized structure
might be just one of the available alternatives. In this respect other
structural organizations of the sequence have been proposed
[40,37]. This quarrel still calls for further experimental evidence, to
be deﬁnitely solved: for example the crystallization of VDAC puriﬁed
from mitochondria and not from recombinant DNA would give a ﬁnal
answer to it.
The sequence homology among VDAC isoforms (Fig. 3) justiﬁes
the ample similarity among secondary structure predictions (Fig. 4).
These data converge on the clear observation that three isoforms
have a very similar structure. When the mouse-VDAC1 X-ray struc-
ture (PDB: 3EMN) is used as a template to build the human VDAC2
and VDAC3 tertiary structure models, the three isoforms showed
that they can be modeled to form similar barrels of 19 amphipathicβ-strands and the N-terminal moiety structured with α-helix seg-
ment(s) [9]. Fig. 5 shows an overposition of the predicted structures
of VDAC2 and VDAC3 isoforms upon VDAC1 coordinates (ﬁle PDB:
3EMN). Of course the structural organization in Fig. 5 is based on
the PDB ﬁle (3EMN).
The N-terminal sequence is located inside the channel, partially
closing the wide pore. The main distinguished difference among the
three isoforms is the extension of 11 amino acids in VDAC2 sequence.
It has been apposed in Fig. 5: a longer strand of the partial α-helical
structure of the N-terminus protrudes outside the pore. Another dif-
ference among the VDAC isoforms are cysteines (Fig. 3 and Table 1):
this point that will be treated in a next section.
4. Functional features of VDAC isoforms
VDAC1 was puriﬁed and characterized from various tissues and
organisms [32]. VDAC2 has been only recently obtained from bovine
spermatozoa [7]. The speciﬁc expression of VDAC3 was observed in
mammalian testes [41] but its puriﬁcation and functional reconsti-
tution has not been achieved, yet. The three isoforms have also
been produced in recombinant systems [42]. Their expression in
yeast and further puriﬁcation from mitochondria represented the
ﬁrst effort to compare functional VDACs [42]. Furthermore, they were
cloned in E.coli expression vectors, where their expression produced a
large amount of protein. VDAC1, in particular, was reconstituted after
refolding procedures and showed the same activity pattern of the pro-
tein puriﬁed from tissues [43,44].
Table 1
Comparison of the amino acid composition of human Vdac isoforms. In yellow the Cysteine content of the proteins is highlighted.
hVDAC1
Calculated Molecular Weight = 30770.05
Estimated pI = 8.68
Amino Acid Composition:
Non-polar: No. Percent
A     21   7.42
V     12   4.24
L     28   9.89
I     11   3.89
P      6   2.12
M      3   1.06
F     14   4.95
W      4   1.41
Polar:  No. Percent
G     32  11.31
S     18   6.36
T     30  10.60
C      2   0.71
Y     11   3.89
N     19   6.71
Q      8   2.83
Acidic: No. Percent
D     14   4.95
E     15   5.30
Basic: No. Percent
K     25   8.83
R      7   2.47
H      3   1.06
hVDAC2
Calculated Molecular Weight = 31563.95
Estimated pI = 8.06
Amino Acid Composition:
Non-polar: No. Percent
A     21   7.14
V     15   5.10
L     23   7.82
I     13   4.42
P     7   2.38
M      3   1.02
F     15   5.10
W      4   1.36
Polar: No. Percent
G     34  11.56
S     23   7.82
T     31  10.54
C      9   3.06
Y     10   3.40
N     15   5.10
Q      8   2.72
Acidic: No. Percent
D     17   5.78
E     12   4.08
Basic: No. Percent
K     23   7.82
R      7   2.38
H      4   1.36
hVDAC3
Calculated Molecular Weight = 30656.04
Estimated pI = 9.05
Amino Acid Composition:
Non-polar: No. Percent
A     22   7.77
V     13   4.59
L     26   9.19
I     11   3.89
P      4   1.41
M      4   1.41
F     15   5.30
W      5   1.77
Polar: No. Percent
G     32  11.31
S     22   7.77
T     26   9.19
C      6   2.12
Y     12   4.24
N     19   6.71
Q      6   2.12
Acidic: No. Percent
D     14   4.95
E     11   3.89
Basic: No. Percent
K     27   9.54
R      4   1.41
H      4   1.41
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outer membrane. The parameters of VDAC1 activity and the recon-
stitution methods were largely reported and we will not write
about them (for reviews see [2,3,8]). We will focus this section on
differences among the VDAC isoforms from mammals. Information
about VDAC activity were obtained from puriﬁed and reconstituted
protein and, in a cellular context, by complementation assays in
yeast cell devoid of the endogenous porin [4] or by gene inactivation
in mouse [45,46].
4.1. Pore-forming activity of VDAC
Functional experiments demonstrated that recombinant VDAC1
and VDAC2 isoforms are able to form pores in lipid bilayers [7,32,42],
but recombinant VDAC3 has no evident pore-forming ability [42].
VDAC2 was obtained by solubilization of whole spermatozoa, con-
taining the cellular mitochondria. Its channel-forming activity was
characterized by a main single-channel conductance of about 3.5 nS in
1 M KCl. Very often small short-lived ﬂuctuations were observed on
top of the conductance steps. These ﬂuctuations were absent for
the puriﬁed VDAC1. VDAC2was anion selective, as VDAC1, and showed
to be similarly voltage-dependent [7]. Recombinant mouse VDAC2
expressed in yeast cells and puriﬁed from yeast mitochondria showed
a similar broad distribution of channels’ sizes, similar ion selectivity
and voltage-dependence [42].
Recombinant VDAC3 (the native protein has never been puriﬁed)
obtained from yeast mitochondria after its expression, was instead
shown to be unable to form pores either after reconstitution in artiﬁ-
cial bilayer or incorporation in liposomes loaded with low molecular
weight molecules [42]. It is not yet clear whether recombinant VDAC3
is unable to form pores or instead unable to insert properly in the
artiﬁcial membranes (Shoshan-Barmatz, unpublished observation).
There are indications that VDAC3 is able to partially vicariate thepore-forming activity of the other isoforms (see below) but a deﬁn-
itive answer is still missing. This main difference between VDAC3
and the other two isoforms, despite the conserved sequence, is
the most puzzling aspects of the VDAC isoforms in mammals.
Voltage dependence is one of the most intriguing aspects of VDAC.
In simple terms, VDAC1 switches to closed states when the trans-
membrane voltage exceeds 20–30 mV. This observation is obtained
in artiﬁcial systems. Transfer of it to the cell would produce a gating
device that could control the bioenergetic metabolism, since, when
in the closed state, VDAC does not allow the regular ﬂux of ATP/ADP
through the membrane. While VDAC1 sub-states (or closed states)
have been extensively characterized [2,3], little is known about this
feature in the other isoforms. VDAC2 showed to mantain voltage de-
pendence features very similar to those of VDAC1 [7]. No relevant
data are presently available about VDAC3. The ability to be voltage-
dependent is a very important issue: it could explain the presence
of three isoforms in the cell, linking them to speciﬁc metabolic
relationships.
4.2. Complementation of yeast porin deﬁcit
The complementation assay in yeast is a useful method that gives
information about the effectiveness of VDAC isoforms to work in
the cellular context. In a situation that force the yeast cell to be
mitochondrial-dependent for its survival, the lack of the endoge-
nous porin causes the yeast to stop its growth. Transformation of
these Δporin yeast strains [4] with plasmids expressing the mam-
malian VDAC isoforms restores the normal growth phenotype
upon mitochondrial-dependent carbon sources. In this condition,
typically, VDAC1 and VDAC2 are able to restore the growth pheno-
type, while VDAC3 is not or it is at a very low level [14,47]. To obtain
quantitative information about the complementation by eutherian
VDACs, the growth curve of yeast was performed, showing that
HVDAC1 HVDAC2 HVDAC3
Fig. 4. Psipred secondary structure predictions of the human VDAC isoforms. The predictions were run at the Psipred server (http://bioinf.cs.ucl.ac.uk/psipred/). For the sake of an
easier comparison, the additional 11-amino acids at the N-terminus of VDAC2 were deleted.
1471A. Messina et al. / Biochimica et Biophysica Acta 1818 (2012) 1466–1476mouse VDAC1 and VDAC2 are able to replicate the growth condi-
tions of the wild type [42]. VDAC3 has a very slow growth curve,
in comparison with the other isoforms and even slower than Δporin
yeast strains (C. Mazzoni, unpublished observation). These quantitative
differences were conﬁrmed by the NADH oxidation assay that exploits
the presence of a NADH dehydrogenase on the outer surface of the
inner membrane [48]. The import of NADH in the inter-membrane
space is only possible when the Δporin yeast is complemented by
VDAC1 and VDAC2 but not by VDAC3 [42].
Cronological life span experiments study the ability of single
yeast cells to form colonies after days of growth. Striking difference
was again noticed when the Δpor1 yeast was transformed with the
human VDAC isoforms. These cells showed to live longer in the pres-
ence of VDAC1 and 2 but also in the presence of VDAC3 that showed a
chronological life-span similar to the wild type. This outlines the im-
portance of the presence of a pore-forming protein in the cell. On the
other hand, VDAC3 showed to be less efﬁcient than VDAC1 and 2 in
restoring the energetic metabolism but anyway able to act as a
porin, at a lower extent [47]. The indication that VDAC3 has the abil-
ity to recover the growth of yeast cells, even though at a lower level
than the other isoforms, means that also VDAC3 is able to form pores
in a cellular context [9,47]. For comparison, experiments of over-
expression in the wild type yeast containing its own porin1 gene
were performed, to investigate the effect of the over-expression of
eutherian VDACs in addition to the physiological levels of the pro-
tein. Interestingly the over-expression of these genes generally re-
duced the viability of the yeast both in glucose and especially inglycerol. This result indicates that the dis-equilibrium of the VDAC
levels is a sensible switch for the cell [9,49].
4.3. Gene knock out in mouse
Gene knock out of single or combination of VDAC genes has been
performed in mouse [45,46,50]. Since this is the subject of another
paper in this issue, we will just brieﬂy summarize these results.
Mouse cell lines containing inactivated VDAC1, 2 or 3 gene were
examined for loss of respiration and any reduction in respiratory
chain activity [51]. ES cells lacking each isoform were viable but
exhibited a ~30% reduction in oxygen consumption. VDAC1 and
VDAC2 deﬁcient cells showed a partial reduction in COX activity,
whereas VDAC3 deﬁcient cells had normal COX activity. These results
indicate that each mouse VDAC isoform is not essential for the cell vi-
ability, since the lack of each of them could be compensated and thus
gave just minor metabolite ﬂux reductions [51]. The ES cells were
used to generate mouse carrying VDAC genes K.O. [45,46]. Only K.O.
mouse for VDAC1 and for VDAC3 have been produced. The VDAC2
K.O. mouse cannot be obtained since VDAC2 deﬁcient embryos are
not viable [52].
The VDAC1 KOmouse is relatively unaffected by the gene inactiva-
tion. Anﬂous et al discovered defects in skeletal muscles and modiﬁ-
cations of kinetic parameters of some mitochondrial enzymes [45].
Ultrastructural changes in muscle mitochondria, where the cristae
become very compact and the mitochondria enlarge many fold, and
a certain degree of in utero lethality were also described [53] but
Parallel ß-strands 1 and 19
A
B
Fig. 5. Overposition of the predicted structures of VDAC2 and VDAC3 upon the PDB:
3EMN coordinates. VDAC1 is blue, VDAC2 is green and VDAC3 is yellow. A: lateral
view of the proteins overposition. B: view from above. The caption in Panel A shows
the two parallel β-strands, namely the strands 19 and 1, a peculiar feature of this
structure. Panel B shows that the N-terminal sequences can be modeled in a similar
way, but the extension of VDAC2, since there is no counterpart in VDAC1 structure,
is just appended. The ﬁgure was obtained with PyMol.
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VDAC1 in the cell were not found.
The VDAC3 KO mouse is again apparently not severely affected by
the genetic deﬁciency [46]. In these mice, substantially healthy, the
main problem is a high degree of male infertility. This problem has
been associated with ultrastructural modiﬁcations in the sperm axo-
neme, leading to sperm immotility. Also, mitochondrial structure
was found to be affected.
As said, the VDAC2−/−mice were never generated. The result was
later explained with the anti-apoptotic function of VDAC2 isoform [52].
The proposed physiological role in vivo for the VDAC2 isoform is as a
speciﬁc inhibitor of BAK-dependent mitochondrial apoptosis [52].
Baines et al.[50] produced the simultaneous ablation of the three
VDAC isoforms by a combination of gene deletion and silencing to
investigate the involvement of these proteins in the mitochondrial
Permeability Transition. These authors proposed that the general-
ized inactivation of these three gene is simply uninﬂuent on the
apoptotic mechanisms involving the Permeability Transition [50].
The absence of the three VDAC isoforms is a situation that should
be lethal or otherwise supported by the opening of other channels
in the outer membrane. This drastic conclusion is hardly compatiblewith living cell, and these data, in our opinion, should need further
investigations and validations.
5. VDAC isoforms and Ca2+
Ca2+ is an important cellular messenger. Since the extensive
number of potential effects, its concentration is kept under strict
control and the ﬂow of the cation in the cell and to the various organ-
elles is very well registered. Mitochondria are a storage site for Ca2+
but the cation, which is an effector for several intra-mitochondrial
enzymes is not freely available. The ﬂow of Ca2+ from outside the
organelle instead is the signaling event that triggers other reactions
and regulates the activity of several enzymes. Once more, VDAC is
located in a critical position, at the entrance of mitochondria, towards
the matrix-speciﬁc Ca2+ transporter systems. Investigations have been
performed on two critical aspects of the VDAC permeability to Ca2+: i)
the inﬂuence of the cation upon the regulation of solute channeling
by the pore; and ii) the involvement of VDAC in structures function-
ally devoted to the cation ﬂow toward the organelle.
The ﬁrst point was studied in [54–56]. For example, the work by
Bathory showed that [Ca2+] regulates the VDAC activity, showing
that only at micromolar, but not at nanomolar, concentration of the
cation, VDAC switches from a closed to an open conductance state
[55]. This result gives a suggestive indication about the regulation of
VDAC and, consequently, of the mitochondria by Ca2+, proposing a
novel mechanism for the control of OMM permeability to ions and
small molecules. At low [Ca2+] the VDAC would not show large con-
ductance state but rather exhibit closed or subconducting states.
Ca2+ addition would open to full conductance the pore [55]. The
mechanism for this behaviour needs a direct interaction of the pore
with the cation. A binding site for Ca2+ has been proposed in Ref.
[57], following the competition between Ca2+ and Ruthenium Red
and its derivative or other cations like La3+ and Tb3+. Ca2+-binding
site(s) would involve peptides labelled by azido ruthenium (AzRu),
a photoactivable compund with the same chemical reactivity of
Ruthenium Red, an inhibitor of VDAC [58]. This picture has been
questioned in Ref. [56]: the inﬂuence of Ca2+ on the pore-forming
activity was not conﬁrmed, asking for more investigation.
VDAC was considered as a molecular actor in the Ca2+ cellular
trafﬁc for the ﬁrst time in [59], when the transient over-expression
of VDAC in HeLa cells and skeletal myotubes increased the mitochon-
drial matrix accumulation of the cation. This has been the ﬁrst indica-
tion of VDAC presence in the routes for Ca2+ transport across the
mitochondrial membranes. Later, the ﬁnding that strict apposition
of ER and mitochondria is mediated by a tethering structure visual-
ized with several techniques like electron tomography [60] conﬁrmed
the proposal that such tethering would involve a component on the
ER, the IP3 receptor, grp75 as tethering component and VDAC on
the outer mitochondrial membrane [61].
The contribution of VDAC isoforms to Ca2+ trafﬁc to mitochondria
has been very recently considered. Di Stefano et al, performed both
selective silencing or over-expression of each human VDAC isoforms,
demonstrating that the mitochondrial Ca2+ transport may occur al-
most indifferently with any VDAC isoform [62]. Silencing of the vari-
ous isoforms, in the presence of a pro-apoptotic stimulus, shows that
they bear a different sensitivity to H2O2, conﬁrming the notion that
VDAC1 is pro-apoptotic and VDAC2 has a pro-survival role in HeLa
cells. Finally, VDAC3 shows no signiﬁcant inﬂuence on apoptosis [62].
During apoptotic events VDAC1 is preferentially involved in tras-
mission of Ca2+ dependent signals to mitochondria, while the other
two isoforms do not show any special perturbation. The inactivation,
by interference, of the IP3R-3 impacts on the protective effect of
VDAC1 silencing.
This work has discriminated, for the ﬁrst time, the role of VDAC
isoforms in Ca2+ trafﬁc: VDAC1 selectively interacts with IP3-Rs and
for this reason it is preferentially involved in the transmission of the
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from VDAC2 and VDAC3, both available for Ca2+ ﬂow, VDAC1 is spe-
ciﬁcally involved in the signalling due to the speciﬁc ﬂow of cations
from the ER, with a regulatory meaning [62].
6. VDAC isoforms, VDAC chimeras and ROS
O2−. is mainly produced by Complex III as a subproduct of the Q
cycle and it can be released both in the matrix and in the intermem-
brane space. The activity of SOD enzymes, that use O2−. as the sub-
strate, produces the other ROS species, in particular H2O2. Since O2−.
cannot freely permeate the membranes, it diffuses to the cytosol via
the pores in the outer mitochondrial membranes [63]. The interaction
of VDAC with O2−. is thus a continuous aspect of the physiology of this
protein. Several investigators have already pointed out this and no-
ticed, for example, that the closure of VDAC with the speciﬁc inhibitor
dextran sulfate decreases the amount of ROS available in the cytosol
[64]. The inhibition of VDAC by a speciﬁc antibody resulted in a
block of the cytochrome C release [59], connecting in this way
the control of ROS formation with the execution of apoptosis. It is
thus not surprising that in systemic surveys reporting the list of pro-
tein modiﬁed due to overload of ROS generating species, VDAC is al-
ways among the most affected protein. In yeast mutants lacking
MnSOD (SOD2) or CuZnSOD (SOD1) superoxide dismutase, it was
found that few, speciﬁc mitochondrial proteins are modiﬁed (carbo-
nylated) to a greater extent than in the wild type after exposure to
paraquat, an oxidant-generating molecule [65]. Despite the action of
superoxide dismutases, some proteins were not efﬁciently protected
and thus were carbonylated. One of the proteins speciﬁcally carbo-
nylated both in the sod1− and in sod2−mutant was the endogenous
yeast porin 1 [65]. The reason for this might be the frequency of con-
tacts with oxidative species, due to role of VDAC in their diffusion.
In mammalian synaptosomes it was found that the exposure to
acrolein, a chemical compound able to improve the carbonylation
of proteins and suspected to cause Alzheimer's disease, enhances
the ratio of carbonylation of VDAC1 13-fold. Only ﬁve proteins
(among them VDAC1) were found exceedingly carbonylated [66].
The mechanism by which acrolein causes oxidative damage and
neurotoxicity is presumed to involve the binding and depletion of
cellular nucleophiles, such as reduced glutathione (GSH), lipoic
acid and thioredoxin. The reaction of acrolein and GSH occurs spon-
taneously at neutral pH. VDAC was identiﬁed as a selectively oxi-
dized target in Alzheimer's Disease brain [67], and it was proposed
that oxidation of this protein could prevent the interaction of
BcLxL with VDAC.
As seen for acrolein, another VDAC modiﬁcation due to ROS action
is the oxidation of the reduced SH group in cysteines. In a systematic
study focused onto the oxidation of protein thiols in yeast, the oxi-
dized proteome of unstressed cells was identiﬁed [68]. In this survey
cysteines were reported to be oxidized at a various extent in 200,
mostly cytoplasmatic, proteins. It was also found that porin 1 is pre-
dominantly present with its cysteines oxidized. ROS can oxidize pro-
tein thiols to thiyl radicals and then to sulfenic, sulﬁnic and sulfonic
acid. Sulfenic acid can react with GSH to form PrSSG, thus preventing
the irreversible oxidation to sulfonic acid. PrSSG is reduced back to
protein thiol very effectively by Glutaredoxin. Saaed et al.[69] down-
regulated Glutaredoxin1 (Grx1) in cell and found that it was speciﬁ-
cally associated with the oxidation of thiol groups of VDAC and
mitochondrial dysfunction. Leﬁevre et al.[70] demonstrated the S-
nitrosylation of VDAC3 in spermatozoa.
Thus VDAC(s) in the outer membrane are the highway of O2−. and
can carry several modiﬁcations, like carbonylation or SH oxidation/
derivatization, due to this role. In general, a drawback of the investi-
gation about VDAC in ROS control, is the lack of consideration of
the different VDAC isoforms. For example, in the work of Han et
al.[64], the authors did not consider that in the outer mitochondrialmembrane there are three different VDACs. Since dextran sulfate
acts as a kind of clog upon the pore and since the VDAC isoforms
are structurally very similar, it is very probable that the overall effect
measured was not speciﬁc of VDAC1 but possibly the sum of the iso-
forms. Another striking difference among the VDAC isoforms is their
cysteine content. Obviously human VDAC2 and VDAC3 with 9 and 6
cysteines, respectively (Table 1), are more subject to SH oxidation
than VDAC1.
In the only work aimed to compare the ROS inﬂuence upon each
VDAC isoform, Reina et al. transformed Δporin1 yeast with each
human VDAC and looked, among the other, into the consequence of
ROS producing agents on yeast containing single, distinct human
VDAC isoforms [47]. Wild type and yeast strains transformed with
human VDACs were compared following various parameters like life
span and resistance to ROS generating agents. Starting point was
the observation that yeast depleted of the endogenous porin is very
sensitive to ROS. Complementation with VDACs restores the yeast
surviving. VDAC3-transformed yeast was constantly the least resis-
tant, while VDAC2 the most. Wild type yeast was also transformed
to study the effect of an over-expression of VDACs. In this condition
VDAC3 showed to be extremely toxic for the cell, resulting in a
complete inhibition at 1.2 mM of H2O2. In apparent contradiction,
the over-expression of VDAC in w.t. yeast showed high level of
ROS. The over-expression of VDAC1 in addition to the yeast porin
led to about 20% of ROS-positive cells, while the over-expression
of VDAC3 led to about 8% of ROS-positive cells. This point was pos-
sibly explained by microscopy observation, showing that DHR123
ﬂuorescence in VDAC1 over-expressing cells was mainly concen-
trated in cellular punctuate structures, probably mitochondria,
while with VDAC3 the ﬂuorescence was diffused [9]. Thus micros-
copy suggests that VDAC1 in some way forces the ROS to remain
in the mitochondrion, while VDAC3 is not active in this respect.
The ROS concentration could lead to the inactivation of mitochon-
drial function that in yeast causes the “petite” phenotype. Petite
cells are unable to use respiratory carbon source. This could explain
the longer lifespan observed in VDAC1 over-expressing cells grown
on glucose [9,47]. On the contrary, cells grown on glycerol cannot
accumulate petite and the VDAC over-expression toxicity is more
evident [9].
VDAC(s) should have a key role in the control of ROS in the cell, as
the many clues reported above seem to indicate. What can be the
mechanism with which VDAC(s) can exert this function and what
can be the difference among the various isoforms? In our opinion
there are two possible mechanisms that could involve the pore-
forming protein(s): i) to be part of the signalling route that from
mitochondria, the source of ROS, switches on genes important for
the cellular inactivation of these reactive species; ii) to be a sort of
molecular buffer in the mitochondria when the overwhelming amount
of ROS cannot be sufﬁciently inactivated by SODs and similar.
A mitochondria-to-nucleus signaling cascades must exist. This
signaling pathway, most likely, can use proteins sensible to ROS in-
crease and stimulate cellular detoxiﬁcation [71]. It is completely
unclear what are the mitochondrial sensors for oxidative stress and
the way they can transmit signals from mitochondria to the nucleus.
If VDAC(s) are involved in such cascade [72], it is tempting to specu-
late that structural modiﬁcations (like carbonylation or cysteine
oxidation or derivatization) might cause conformational changes
in mobile moieties of VDAC(s) (Fig. 6). Due to the expected rigidity
of the pore walls, possible candidate to this role could be the N-
terminal sequences of VDAC2 and VDAC3. Each of them contains
two cysteines partially exposed to the water environment. Data
from yeast complementation assay with human isoforms suggest
that VDAC1 and VDAC2 are important for the ROS control, as it is
for the endogenous yeast porin1. VDAC3 looks instead unable to
exhert such a role. This has been conﬁrmed by swapping experi-
ments where the VDAC3 N-terminal sequence was substituted
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H+ H+ H+
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Fig. 6. A cartoon depicting potential role of VDAC(s) and their cysteines as mediator in the ROS signaling route mitochondria-to-nucleus. O.M.: outer membrane, I.M.: inner
membrane, CI, CIII, CIV: cartoon of H+ pumping mitochondrial OxPhos Complexes. Grey barrels represent VDAC(s) with cysteines carrying S in different oxidation states.
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VDACx-VDAC3 were able to restore the ROS control [47]. The con-
clusion is that the N-terminal sequence could be the important
part of the protein for the ROS control. Another point is the different
impact of VDAC3 and VDAC2 cysteines. Since VDAC3 is not able to con-
trol ROS, either its cysteines are not involved in this role or just act as
chemical buffer for ROSmodiﬁcations. In a last hypothesis VDAC3 cyste-
ines cannot be involved in this function just because they already are in
an oxidized state.7. Conclusions
In this review we have tried to give a whole comparative report
of the information available in the literature about the VDAC iso-
forms in mammals. A missing chapter is the involvement of VDAC
isoforms in the germinal tissue. This intriguing point has been
aroused with the discovery that VDAC3 KO mouse are male infertile
because their sperm axoneme is not properly formed [46]. Next,
other reports have been focused on mammalian spermatozoa (but
similar interesting insights come from Drosophila, too [73,74])
showing that the localization of VDAC isoforms may not be canoni-
cal in this cell [41]. VDAC presence should be important in the devel-
opment of germinal cells or in their ultrastructural organization. In
particular VDAC2 and 3 are largely transcribed in the precursor of
spermatozoa [75]. Recently the presence of VDAC in the plasmalem-
ma of ovaries has also been shown [76]. Spermatozoa are very spe-
cialized and subcompartmentalized cells and they bear noteworthy
differences among closely related species. Thus a comparative anal-
ysis of VDAC isoforms roles in these cells is still too early because not
enough is known about the localization and function of VDACs in
this context. There is no doubt, however, that this chapter is des-
tined to become an active and surprising research ﬁeld.
VDAC isoforms in mammals have differentiated roles, since the
number of functional differences that is emerging in the last years
justiﬁes the evolution of three genes. VDAC isoforms show meaning-
ful differences in their pore-forming function, Ca2+ sensitivity, ROS
control. In the next years, the ﬁne, molecular mechanisms of their co-
ordination and function will be the frontier of research in the ﬁeld.Acknowledgements
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